0001493152-24-012832.txt : 20240402
0001493152-24-012832.hdr.sgml : 20240402
20240402165841
ACCESSION NUMBER: 0001493152-24-012832
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240329
FILED AS OF DATE: 20240402
DATE AS OF CHANGE: 20240402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hakim Nasrat A
CENTRAL INDEX KEY: 0001583742
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15697
FILM NUMBER: 24815293
MAIL ADDRESS:
STREET 1: C/O ELITE PHARMACEUTICALS, INC.
STREET 2: 165 LUDLOW AVE.
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/
CENTRAL INDEX KEY: 0001053369
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 223542636
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
BUSINESS PHONE: 2017502646
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
FORMER COMPANY:
FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/
DATE OF NAME CHANGE: 19980121
4
1
ownership.xml
X0508
4
2024-03-29
0
0001053369
ELITE PHARMACEUTICALS INC /NV/
ELTP
0001583742
Hakim Nasrat A
C/O ELITE PHARMACEUTICALS,
INC., 165 LUDLOW AVE.
NORTHVALE
NJ
07647
1
1
1
0
CEO, President
0
Common Stock
2024-03-29
4
A
0
49534368
0.00
A
216649250
D
Common Stock
2700000
I
by IRA
Common Stock
2223147
I
by Kristine Hakim
Shares issued in settlement of compensation owed to the Reporting Person pursuant to his Employment Agreement with the issuer, dated August 1, 2013, as amended.
Nasrat A Hakim
2024-04-02